Pharmacoeconomics: Open Access

Volume 10, Issue 6 (2025)

Brief Report Pages: 1 - 2

Value Assessment Of High-cost Specialty Drugs

Paula RÃos CalderÃ³n*

DOI: 10.37421/2472-1042.2025.10.311

Share this article

Brief Report Pages: 1 - 3

Valuing High-cost Specialty Drugs: A New Era

Stefan Novak*

DOI: 10.37421/2472-1042.2025.10.312

Share this article

Opinion Pages: 1 - 3

Drug Repurposing: Economic Gains, Faster Pathways, Rare Diseases

Leila Moradi*

DOI: 10.37421/2472-1042.2025.10.313

Share this article

Opinion Pages: 1 - 3

Metabolic Drug Therapy: Long-Term Healthcare Savings

Peter Van Loon*

DOI: 10.37421/2472-1042.2025.10.314

Share this article

Commentary Pages: 1 - 3

Pharmacotherapy: Economic Benefits for Chronic Metabolic Disorders

Mette Rasmussen*

DOI: 10.37421/2472-1042.2025.10.315

Share this article

Commentary Pages: 1 - 3

Pharmacoeconomics: Valuing Precision Medicine?s Complex Future

Jose Ignacio Fuentes*

DOI: 10.37421/2472-1042.2025.10.316

Share this article

Perspective Pages: 1 - 2

Pharmacy Services: Saving Costs, Improving Outcomes

Linh Tran Nguyen*

DOI: 10.37421/2472-1042.2025.10.317

Share this article

Perspective Pages: 1 - 3

NEML Budgets: Challenges, Strategies, and Sustainable Integration

Robert J. Caldwell*

DOI: 10.37421/2472-1042.2025.10.318

Share this article

Short Communication Pages: 1 - 3

Preventive Drugs for Older Adults: Health and Economic Benefits

Salma Bouchard*

DOI: 10.37421/2472-1042.2025.10.319

Share this article

Short Communication Pages: 1 - 3

Oncology Pharmacoeconomics: Guiding Decisions, Valuing Therapies

Emil Kowalczyk*

DOI: 10.37421/2472-1042.2025.10.320

Share this article

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report

Citations: 106

Pharmacoeconomics: Open Access received 106 citations as per Google Scholar report

Volume 10, Issue 6 (2025)

Value Assessment Of High-cost Specialty Drugs

Valuing High-cost Specialty Drugs: A New Era

Drug Repurposing: Economic Gains, Faster Pathways, Rare Diseases

Metabolic Drug Therapy: Long-Term Healthcare Savings

Pharmacotherapy: Economic Benefits for Chronic Metabolic Disorders

Pharmacoeconomics: Valuing Precision Medicine?s Complex Future

Pharmacy Services: Saving Costs, Improving Outcomes

NEML Budgets: Challenges, Strategies, and Sustainable Integration

Preventive Drugs for Older Adults: Health and Economic Benefits

Oncology Pharmacoeconomics: Guiding Decisions, Valuing Therapies

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report

Citations: 106

Pharmacoeconomics: Open Access peer review process verified at publons

Indexed In

Related Links

Open Access Journals